Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Batch to batch consistency testing ensures researchers can rely on uniform compound characteristics across multiple studies
It is still too early to draw definitive conclusions, but the numerous ongoing clinical trials, including the cardiovascular safety trial versus an active comparator (dulaglutide), the first of its kind, will provide us shortly with important confirmations
About the Compound AOD-9604 is a synthetic 16-amino-acid peptide with the sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (YLRIVQCRSVEGSCGF) stabilized by a disulfide bond between the two cysteine residues
the design is intended to extend half-life and reduce the amyloid-aggregation tendency of native human amylin while retaining amylin-receptor agonist activity
Your dose needs may change if you become pregnant, if you breastfeed, or if you eat a vegetarian diet
[ CrossRef ] [ Google scholar ] [ PubMed ] Pickart L, Vasquez-Soltero JM, Margolina A
